In human MG, elevated expression of TRAIL receptors DR4 and DR5 has been observed in the thymus, highlighting a potential role for TRAIL in shaping thymic T cell composition and central tolerance mechanisms (38). The gene discussed is TNFSF10; the disease is myasthenia gravis.